SG10201402034PA - Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid - Google Patents

Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid

Info

Publication number
SG10201402034PA
SG10201402034PA SG10201402034PA SG10201402034PA SG10201402034PA SG 10201402034P A SG10201402034P A SG 10201402034PA SG 10201402034P A SG10201402034P A SG 10201402034PA SG 10201402034P A SG10201402034P A SG 10201402034PA SG 10201402034P A SG10201402034P A SG 10201402034PA
Authority
SG
Singapore
Prior art keywords
synthesis
ivabradine
application
addition salts
acceptable acid
Prior art date
Application number
SG10201402034PA
Inventor
Vaysse-Ludot Lucile
Le Flohic Alexandre
Vaultier Michel
Pucheault Mathieu
Kaminski Thomas
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of SG10201402034PA publication Critical patent/SG10201402034PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06One of the condensed rings being a six-membered aromatic ring the other ring being four-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCESS FOR THE SYNTHESIS OF 3,4-DIMETHOXYBICYCLO[4.2.()]OCTA- l,3,5-TRIENE-7-CARBONITRILE, AND APPLICATION IN THE SYNTHESIS OF IVABRADINE AND ADDITION SALTS THEREOF WITH A 5 PHARMACEUTICALLY ACCEPTABLE ACID Process for the synthesis of the compound of formula (I): Application in the synthesis of ivabradine, addition salts thereof with a pharmaceutieally acceptable acid and hydrates thereof.
SG10201402034PA 2013-05-17 2014-05-05 Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid SG10201402034PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1354504A FR3005658B1 (en) 2013-05-17 2013-05-17 "PROCESS FOR THE SYNTHESIS OF 3,4-DIMETHOXYBICYCLO [4.2.0] OCTA-1,3,5-TRIENE-7-CARBONITRILE, AND APPLICATION TO THE SYNTHESIS OF IVABRADINE AND ITS SALTS OF ADDITION TO A PHARMACEUTICALLY ACCEPTABLE ACID "

Publications (1)

Publication Number Publication Date
SG10201402034PA true SG10201402034PA (en) 2014-12-30

Family

ID=48874340

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201402034PA SG10201402034PA (en) 2013-05-17 2014-05-05 Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid

Country Status (36)

Country Link
US (1) US8859763B1 (en)
EP (1) EP2803659B1 (en)
JP (1) JP5916793B2 (en)
KR (1) KR101625128B1 (en)
CN (1) CN104163777B (en)
AR (1) AR096324A1 (en)
AU (1) AU2014202434B2 (en)
BR (1) BR102014011633A2 (en)
CA (1) CA2851960C (en)
CY (1) CY1120482T1 (en)
DK (1) DK2803659T3 (en)
EA (1) EA026224B1 (en)
ES (1) ES2621804T3 (en)
FR (1) FR3005658B1 (en)
GE (1) GEP20156416B (en)
HK (2) HK1200028A1 (en)
HR (1) HRP20170394T1 (en)
HU (1) HUE031370T2 (en)
IN (1) IN2014DE01203A (en)
JO (1) JO3276B1 (en)
LT (1) LT2803659T (en)
MD (1) MD4443C1 (en)
ME (1) ME02636B (en)
MX (1) MX345278B (en)
NZ (1) NZ624774A (en)
PL (1) PL2803659T3 (en)
PT (1) PT2803659T (en)
RS (1) RS55917B1 (en)
SA (1) SA114350532B1 (en)
SG (1) SG10201402034PA (en)
SI (1) SI2803659T1 (en)
TW (1) TWI500596B (en)
UA (1) UA116337C2 (en)
UY (1) UY35561A (en)
WO (1) WO2014184501A1 (en)
ZA (1) ZA201403543B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3005658B1 (en) * 2013-05-17 2015-04-24 Servier Lab "PROCESS FOR THE SYNTHESIS OF 3,4-DIMETHOXYBICYCLO [4.2.0] OCTA-1,3,5-TRIENE-7-CARBONITRILE, AND APPLICATION TO THE SYNTHESIS OF IVABRADINE AND ITS SALTS OF ADDITION TO A PHARMACEUTICALLY ACCEPTABLE ACID "
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (en) * 1991-09-27 1993-11-12 Adir Cie NOVELS (BENZOCYCLOALKYL) ALKYLAMINES, THEIR PREPARATION PROCESS, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2870537A1 (en) * 2004-05-19 2005-11-25 Servier Lab NOVEL PROCESS FOR SYNTHESIZING (1S) -4,5-DIMETHOXY-1- (METHYL AMINOMETHYL) BENZOCYCLOBUTANE AND ITS ADDITION SALTS AND APPLICATION TO THE SYNTHESIS OF IVABRADINE AND ITS ADDITION SALTS PHARMACEUTICALLY ACCEPTABLE ACID
FR2933975B1 (en) * 2008-07-17 2011-02-18 Servier Lab NOVEL PROCESS FOR THE PREPARATION OF FUNCTIONALIZED BENZOCYCLOBUTENES, AND APPLICATION TO THE SYNTHESIS OF IVABRADINE AND ITS SALTS OF ADDITION TO A PHARMACEUTICALLY ACCEPTABLE ACID
WO2011138825A1 (en) 2010-05-06 2011-11-10 株式会社島津製作所 Material testing machine
HUP1000245A2 (en) * 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
FR3005658B1 (en) * 2013-05-17 2015-04-24 Servier Lab "PROCESS FOR THE SYNTHESIS OF 3,4-DIMETHOXYBICYCLO [4.2.0] OCTA-1,3,5-TRIENE-7-CARBONITRILE, AND APPLICATION TO THE SYNTHESIS OF IVABRADINE AND ITS SALTS OF ADDITION TO A PHARMACEUTICALLY ACCEPTABLE ACID "

Also Published As

Publication number Publication date
FR3005658B1 (en) 2015-04-24
KR20140135658A (en) 2014-11-26
MD4443B1 (en) 2016-11-30
HK1199872A1 (en) 2015-07-24
TW201446712A (en) 2014-12-16
PT2803659T (en) 2017-02-14
AU2014202434A1 (en) 2014-12-04
HUE031370T2 (en) 2017-07-28
AR096324A1 (en) 2015-12-23
EP2803659A1 (en) 2014-11-19
CY1120482T1 (en) 2019-07-10
GEP20156416B (en) 2015-12-10
WO2014184501A1 (en) 2014-11-20
MX345278B (en) 2017-01-24
NZ624774A (en) 2015-03-27
ME02636B (en) 2017-06-20
MD20140048A2 (en) 2014-11-30
HRP20170394T1 (en) 2017-05-05
EA201400473A1 (en) 2014-12-30
RS55917B1 (en) 2017-09-29
JO3276B1 (en) 2018-09-16
JP2014237636A (en) 2014-12-18
CN104163777B (en) 2016-06-29
SI2803659T1 (en) 2017-04-26
UY35561A (en) 2014-11-28
CN104163777A (en) 2014-11-26
BR102014011633A2 (en) 2015-06-02
CA2851960A1 (en) 2014-11-17
PL2803659T3 (en) 2017-06-30
ZA201403543B (en) 2015-07-29
LT2803659T (en) 2017-02-27
US8859763B1 (en) 2014-10-14
EP2803659B1 (en) 2017-01-04
UA116337C2 (en) 2018-03-12
HK1200028A1 (en) 2015-07-31
CA2851960C (en) 2016-04-19
KR101625128B1 (en) 2016-05-27
ES2621804T3 (en) 2017-07-05
EA026224B1 (en) 2017-03-31
IN2014DE01203A (en) 2015-06-05
AU2014202434B2 (en) 2017-11-02
MX2014005822A (en) 2014-11-20
MD4443C1 (en) 2017-06-30
SA114350532B1 (en) 2015-07-09
JP5916793B2 (en) 2016-05-11
FR3005658A1 (en) 2014-11-21
TWI500596B (en) 2015-09-21
DK2803659T3 (en) 2017-04-10

Similar Documents

Publication Publication Date Title
MY150014A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
JO2930B1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MY145611A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SA113340722B1 (en) Process for the enzymatic synthesis of (7S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-Trien-7-yl) N-methyl methanamine, and application in the synthesis of ivabradine and salts thereof
JO2854B1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MY159701A (en) New process for the synthesis of (2e)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SG10201402034PA (en) Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MY170662A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MY159691A (en) New process for the synthesis of 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MX347536B (en) Process for the enzymatic synthesis of (7s)-3,4-dimethoxybicyclo[ 4.2.0]octa-1,3,5-triene-7-carboxylic acid and application in the synthesis of ivabradine and salts thereof.
SA113340924B1 (en) New process for the synthesis of 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
JO3083B1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SA114350383B1 (en) Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine
JO3086B1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SG165255A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid